http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102159276-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 |
| filingDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102159276-B1 |
| titleOfInvention | A pharmaceutical composition comprising decursin derivatives for preventing or treating CYP4 family related diseases |
| abstract | The present invention relates to a pharmaceutical composition for the prevention or treatment of cardiovascular diseases related to CYP4 (cytochrome P450 4 family) comprising a decursine derivative represented by Formula 1 as an active ingredient. The decursine derivative has excellent selective inhibitory activity against CYP4 series enzymes among the CYP series, so it can be usefully used as a pharmaceutical composition for the prevention or treatment of CYP4-related cardiovascular diseases such as myocardial infarction, angina, heart failure, ischemia-reperfusion injury and hypertension I can. |
| priorityDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.